Stock CTLT CATALENT, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Catalent, Inc.

Equities

CTLT

US1488061029

Market Closed - Nyse
Other stock markets
 04:00:02 2024-05-21 pm EDT 		5-day change 1st Jan Change
54.96 USD -0.07% Intraday chart for Catalent, Inc. -1.01% +22.32%
May. 16 Argus Downgrades Catalent to Sell From Buy MT
May. 14 Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal MT

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal
MT
Novo Nordisk Plans First Bond Sale in Two Years
MT
MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman
RE
Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.07B
MT
Catalent, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024
CI
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer
CI
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition
MT
Catalent, Novo Nordisk Antitrust Review Extended by FTC
MT
FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal
DJ
US FTC seeks more information on Novo Nordisk parent-Catalent deal
RE
FTC seeks more information on Novo Holdings-Catalent deal
RE
Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast
RE
Obesity drugmaker Novo Nordisk's Q1 profit beats forecast
RE
Sector Update: Health Care Stocks Decline Late Afternoon
MT
Sector Update: Health Care Stocks Flat to Higher Premarket Monday
MT
Novo Nordisk Parent Resubmits US Antirust Application for Catalent Acquisition
MT
Novo Nordisk parent refiles US application on Catalent deal
RE
Novo Nordisk owner refiles U.S. application for approval of Catalent deal
RE
Invenra Inc. Announces Strategic Collaboration with Catalent to Co-Discover Novel Bispecific ADCs
CI
Novo Nordisk hopes to launch experimental obesity drug this decade
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CTLT Stock
  4. News Catalent, Inc.
  5. Highlights
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW